UFP Technologies announces CEO R. Jeffrey Bailly's retirement, effective June 2026, transitioning to President Mitchell Rock.
Quiver AI Summary
UFP Technologies, Inc. announced that CEO R. Jeffrey Bailly will retire at the company's annual meeting on June 4, 2026, after serving in the role for 31 years. Mitchell Rock, currently the President, will take over as CEO and join the Board of Directors. To ensure a smooth leadership transition, Bailly will become the Executive Chairman of the Board for one year. Under Bailly's leadership, the company's revenue grew significantly, and he expressed pride in the team's accomplishments and confidence in Rock's capabilities as the new CEO. Rock expressed gratitude for Bailly's mentorship and is committed to continuing the company's successful strategy and fostering strong relationships with customers and stakeholders.
Potential Positives
- R. Jeffrey Bailly, the long-standing CEO with a 31-year tenure, is transitioning to Executive Chairman, ensuring leadership continuity during the changeover to new CEO Mitch Rock.
- Mitch Rock, who has been with the company for 25 years and is well-respected in the industry, is stepping into the CEO role, indicating a stable leadership transition.
- Under Bailly's leadership, the company experienced approximately 20-fold revenue growth and over 150-fold growth in profitability and market capitalization, highlighting its successful operational strategies.
Potential Negatives
- The announcement of CEO R. Jeffrey Bailly's retirement after 31 years could raise concerns about leadership continuity and the impact of this transition on company stability and strategy.
- Mitch Rock's assumption of the CEO role may lead to uncertainty regarding the company's direction, as an internal promotion may not always align with new strategic insights that external leadership could bring.
- The lengthy tenure of Bailly, while seen as a positive, may result in apprehension about the company's adaptability to new market trends and innovations under new leadership.
FAQ
Who will replace R. Jeffrey Bailly as CEO of UFP Technologies?
Mitchell Rock, currently the President of UFP Technologies, will assume the CEO position.
When is R. Jeffrey Bailly retiring?
R. Jeffrey Bailly will retire as CEO at the Company’s annual meeting on June 4, 2026.
What role will R. Jeffrey Bailly have after retirement?
After retirement, he will serve as Executive Chairman of the Board for one year.
How long has R. Jeffrey Bailly been CEO of UFP Technologies?
R. Jeffrey Bailly has served as CEO for 31 years.
What is UFP Technologies known for?
UFP Technologies specializes in contract development and manufacturing of single-use and single-patient medical devices.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$UFPT Insider Trading Activity
$UFPT insiders have traded $UFPT stock on the open market 12 times in the past 6 months. Of those trades, 0 have been purchases and 12 have been sales.
Here’s a breakdown of recent trading of $UFPT stock by insiders over the last 6 months:
- DANIEL C CROTEAU has made 0 purchases and 2 sales selling 2,873 shares for an estimated $591,883.
- CHRISTOPHER P. LITTERIO (Senior Vice President) has made 0 purchases and 10 sales selling 1,829 shares for an estimated $415,549.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$UFPT had revenues of $154.6M in Q3 2025. This is an increase of 6.47% from the same period in the prior year.
You can track UFPT financials on Quiver Quantitative's UFPT stock page.
$UFPT Hedge Fund Activity
We have seen 133 institutional investors add shares of $UFPT stock to their portfolio, and 169 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- INVESCO LTD. removed 149,367 shares (-84.9%) from their portfolio in Q3 2025, for an estimated $29,813,653
- ROCKEFELLER CAPITAL MANAGEMENT L.P. added 86,128 shares (+inf%) to their portfolio in Q3 2025, for an estimated $17,191,148
- ALLSPRING GLOBAL INVESTMENTS HOLDINGS, LLC added 85,457 shares (+469.4%) to their portfolio in Q3 2025, for an estimated $17,057,217
- MOUNTAIN PACIFIC INVESTMENT ADVISERS LLC removed 81,516 shares (-82.4%) from their portfolio in Q3 2025, for an estimated $16,270,593
- GENEVA CAPITAL MANAGEMENT LLC added 74,461 shares (+88.6%) to their portfolio in Q3 2025, for an estimated $14,862,415
- AMERICAN CENTURY COMPANIES INC removed 71,515 shares (-22.0%) from their portfolio in Q3 2025, for an estimated $14,274,394
- MILLENNIUM MANAGEMENT LLC removed 64,920 shares (-95.9%) from their portfolio in Q3 2025, for an estimated $12,958,032
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$UFPT Analyst Ratings
Wall Street analysts have issued reports on $UFPT in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Lake Street issued a "Buy" rating on 08/06/2025
To track analyst ratings and price targets for $UFPT, check out Quiver Quantitative's $UFPT forecast page.
Full Release
NEWBURYPORT, Mass., Dec. 02, 2025 (GLOBE NEWSWIRE) -- UFP Technologies, Inc. (Nasdaq: UFPT), a contract development and manufacturing organization that specializes in single-use and single-patient medical devices, today announced that R. Jeffrey Bailly will retire as CEO at the Company’s next annual meeting on June 4, 2026. At that time, Mitchell Rock, President of the Company, will assume the CEO position and join the Company’s Board. To facilitate a smooth transition, Mr. Bailly will serve as Executive Chairman of the Board for the following year.
“Serving as CEO for 31 years, Jeff has been an extremely effective leader who, together with his team, transitioned the company to a leading global contract development and manufacturing organization focused on medical markets, with locations in five countries,” said Dan Croteau, Lead Director of the Board. “During Jeff’s tenure, the Company’s revenue grew approximately 20-fold, and profitability and market capitalization grew more than 150-fold. We thank Jeff for his significant contributions, wish him all the best in his retirement, and look forward to his continued impact as Executive Chairman.”
“It has been my honor to lead the exceptional, innovative, and customer-focused team at UFP Technologies, whose dedication, hard work, and can-do attitude have made it the success it is today,” said Bailly. “I am extremely proud of this team of nearly 5,000 associates and all they have done, and continue to do, to make our customers successful. I am very grateful to all of them and to our Board of Directors. I am also very excited about the future of the company under Mitch Rock’s leadership. He has been a strategic partner for 25 years and is a very capable leader who is well-respected throughout our industry. With his deep understanding of the markets we serve, his strong relationships with our key customers and vendor partners, and the trust and respect of his co-workers, Mitch is the natural choice to be UFP’s next CEO.”
“I’m honored by the Board’s confidence and grateful for Jeff’s leadership and mentorship over many years,” said Mitch Rock, President. “As he transitions to Executive Chairman, I look forward to continuing our close partnership and building on our strong foundation. UFP Technologies has highly talented people, trusted customer relationships, and many exciting market opportunities. I’m committed to continuing to execute our proven strategy to deliver long-term value for our customers, team members, and shareholders.”
About UFP Technologies, Inc.
UFP Technologies is a contract development and manufacturing organization that specializes in single-use and single-patient medical devices. UFP is a vital link in the medical device supply chain and a valued outsourcing partner to many of the world's top medical device manufacturers. The Company’s single-use and single-patient devices and components are used in a wide range of medical devices and packaging for minimally invasive surgery, infection prevention, wound care, wearables, orthopedic soft goods, and orthopedic implants.
Contact: Ron Lataille
978-234-0926, [email protected]